Chinas

China’s big silver squeeze persists even as prices steady
China’s big silver squeeze persists even as prices steady
Published Wed, Feb 11, 2026 · 10:56 AMINTERNATIONAL silver prices have steadied after an epic bout of turbulence, but supplies in China are still being pinched as investment and...
China’s stock exchanges to facilitate refinancing for listed firms
China’s stock exchanges to facilitate refinancing for listed firms
The Shanghai, Shenzhen and Beijing bourses say this is to reform the country’s capital markets and promote innovationPublished Mon, Feb 9, 2026 · 09:41 PM[BEIJING] The Chinese stock exchanges...
China’s easy money floods metals markets as real economy falters
China’s easy money floods metals markets as real economy falters
Copper, gold and silver all hit record highs, and activity on Chinese futures markets has soaredPublished Fri, Feb 6, 2026 · 01:49 PMWITH ample cash but fewer investment options,...
China’s BYD vehicle sales fall for fifth month in a row
China’s BYD vehicle sales fall for fifth month in a row
It has narrowly met its slashed global sales target of 4.6 million units in 2025, and has not announced this year’s targetPublished Sun, Feb 1, 2026 · 07:16 PM[BEIJING/HONG...
After EVs, smart driving tech to power China’s auto exports
After EVs, smart driving tech to power China’s auto exports
China exported a record 7.1 million cars in 2025, buoyed by growing demand for new-energy vehicles (NEVs) as the global shift toward electrification gathered pace, allowing the country to...
AstraZeneca strikes deal for up to US.5 billion to license weight-loss drugs from China’s CSPC
AstraZeneca strikes deal for up to US$18.5 billion to license weight-loss drugs from China’s CSPC
The deal builds on existing collaboration between the companies in areas such as artificial intelligencePublished Fri, Jan 30, 2026 · 08:50 PM[SHANGHAI] AstraZeneca will license experimental drugs for obesity...
AstraZeneca strikes deal for up to US.5 billion to license weight-loss drugs from China’s CSPC
AstraZeneca strikes deal for up to US$18.5 billion to license weight-loss drugs from China’s CSPC
The deal builds on existing collaboration between the companies in areas such as artificial intelligencePublished Fri, Jan 30, 2026 · 08:50 PM[SHANGHAI] AstraZeneca will license experimental drugs for obesity...
China’s four-year energy spree has eclipsed entire US power grid
China’s four-year energy spree has eclipsed entire US power grid
Published Wed, Jan 28, 2026 · 01:02 PMCHINA is undertaking an energy-building boom unlike anything the world has ever seen, as Beijing seeks to ensure supply for power-hungry facilities...
China’s low birthrate isn’t doomsday for formula milk suppliers
China’s low birthrate isn’t doomsday for formula milk suppliers
Falling birthrates, a phenomenon across richer countries, are obviously a drag on firms that make products for childrenPublished Mon, Jan 26, 2026 · 09:02 AM[MELBOURNE] China’s shockingly low birthrate...
China’s AI stocks with killer apps are winning investor favour
China’s AI stocks with killer apps are winning investor favour
Profitable app makers are trading more cheaply than some of the more overheated tech segmentsPublished Fri, Jan 23, 2026 · 10:18 AM[HONG KONG] As China’s homegrown artificial intelligence (AI)...